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Abstract 
Background: The aim of this case-control study was to estimate the diagnostic accuracy of the 
standard clinical parameters in diagnosing healthy peri-implant tissues, peri-implant mucositis, and 
peri-implantitis. 
 
Methods: A case-control study was designed to compare the clinical parameters used in the diagnosis 
of peri-implant diseases such as: probing pocket depth (PPD), bleeding on probing (BOP), mucosal 
redness (MR), suppuration (SUP), and plaque index (PI). Furthermore, the influence of patient- 
(gender, age) and implant-related variables (implant neck configuration, time in function after 
loading) were evaluated to investigate the association with the clinical findings. The inferential 
analysis consisted of estimation by generalized estimating equations (GEE) of multilevel logistic 
regression models.  
 
Results: In total, 1572 sites were evaluated around 262 implants from 141 patients. Sites with implant 
mucositis showed significant levels of BOP (OR=3.56), MR (OR=7.66) and PPD (OR=1.48) 
compared to healthy sites. The specificity was 90.3% while the sensitivity was only 43.6%.  Likewise, 
Sites exhibiting peri-implantitis showed significant levels of BOP (OR=2.32), MR (OR=7.21), PPD 
(OR=2.43) and SUP (OR=6.81) compared to healthy sites. Again, the multiple logistic regressions 
showed high specificity (92.1%) but modest sensitivity (52.5%). PPD was the only diagnostic marker 
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Moreover, tissue-level compared to bone-level implants were less associated with SUP+ (OR=0.20), 
and PI (OR=0.36) and demonstrated statistical significance. In addition, age, gender and function time 
significantly influenced the tested clinical parameters.  
 
Conclusion: The diagnosis of peri-implant diseases cannot rely solely upon individual clinical 
parameters but rather require a combination of criteria. The clinical parameters, particularly probing 
pocket depth, might accurately discern between diagnoses among peri-implant conditions. 
Nevertheless, the specificity of the clinical parameters surpasses the sensitivity in the detection of 
peri-implant diseases, validating its potential use as a diagnostic tool (NCT 03031392). 
 
Introduction 
Peri-implant diseases is becoming a more common condition, reaching a frequency of 30-40% 
determined at the implant-level.
1
 Such a condition was first described in 1965 as soft tissue 
inflammation and concomitant bone destruction.
2
 Later, as the fields of implantology and 
microbiology advanced, peri-implantitis was described as an imbalance in the bacterial load and  host 
response.
3
 Subsequently, mucositis was paralleled with gingivitis and peri-implantitis to chronic 
periodontitis, and certain putative bacteria were capable of inducing the observed inflammatory 
response. Hence, mucositis and peri-implantitis were considered pathological counterparts of 
gingivitis and periodontitis on implants,
4
 while the keystone periopathogens were considered 
responsible for induction of the local immunological dysbiosis.
5
 However, recent research revealed 
that periodontal and peri-implant pathologies express different pathological characteristics since peri-
implant lesions demonstrated more aggressive behavior and follow a progressive course
6
 In parallel, it 
was shown that treatment protocols adopted from periodontology provided unpredictable outcomes on 
implants with high recurrence rates.
7
 Hence, peri-implant diseases were defined as important 




Moreover, the high rate of inconsistency among case definitions was identified as an initial problem; 
thus, the European Federation of Periodontology (EFP) along with the American Academy of 
Periodontology (AAP) held a series of consensus meetings to define peri-implant diseases based on 
clinical and radiographic features.
10-13
 Hence, it was emphasized that there was a need for 
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such, it was agreed that the hemostatic biologic bone remodeling triggers up to a maximum acceptable 
threshold of 2mm bone loss.
10-13
 Pathologic bone loss was defined as progressive bone loss beyond 




It is important to acknowledge that peri-implant tissues histologically depict different anatomical 
structures when compared to the periodontium due to lack of two periodontal tissues, which 
compromises homeostatic potential to abrogate infective and biomechanical threats. While evolution 
has created a tight attachment to dentition surface via the long-junctional epithelium in the 
periodontium, peri-implant tissues are primarily supported with loose and parallel-oriented fibers, 
providing a compromised coronal seal.
14
 As such, the low diagnostic accuracy and sensitivity of 
probing pocket depth does not seem to accurately reflect disease/healthy condition per se when 
compared to natural dentition.
15, 16
 Moreover, the lack of standardization in dental implant macro- and 
micro-design leads to difficulty in reaching reproducible diagnostic tools.
10 
Nevertheless, probing 
pocket depth might still be a good diagnostic indicator but it is often suggested to combine the 




Bleeding on probing is reported to have a high specificity and reasonable sensitivity to detect 
periodontitis.
18-20
 Again, understanding the weak hemidesmosome attachment to the implant surface is 
imperative to discern appropriate probe penetration and bleeding. In the presence of inflammation, 
bleeding should be present indicating high sensitivity when probing deeper sites;
21
 however, the lack 
thereof in healthy condition does not seem to translate with high specificity.
22
 In this regard, it is 
noteworthy to mention that the mucogingival shift after implant placement often decreases the 
presence of keratinized mucosa, triggering a greater inflammatory status on the peri-implant tissues.
23
 
Thereupon, bleeding on probing, although it might reliably indicate presence of disease, does not 
seem to be a suitable single diagnostic parameter for peri-implantitis. On the other side, suppuration is 
caused by necrosis of peri-implant tissues, rich in polymorphonuclear cells. Thus, suppuration is 
logically and statistically a sensitive indicator of bone turnover.
24
 In this scenario, it must be noted 
that, if detected in early stages where bone resorption has not occurred yet, it might be a consequence 
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Therefore, although the use of clinical parameters with radiological proof of bone changes represents 
a “gold standard”, the diagnostic value of clinical parameters of implants is still controversially 
reported and not well defined.
10
 Standardization of the diagnostic parameter implies well defined 
methodological approach intended to estimate the accuracy, precision, sensitivity and specificity of 
the parameter to distinguish different states of the target tissue or organ. The main pre-condition for 
reliable estimates is the use of a strict case definition and related criteria as well as use of appropriate 
analytical methods for data analysis. To the best of our knowledge, this is the first study to estimate 
diagnostic accuracy of the clinical parameters on implants using multiple analytical methods indicated 
for validation of diagnostic parameters.  It is of the authors’ hypothesis that assessment of multiple 
clinical parameters will provide more accurate diagnostic information than independent parameters in 
evaluation of peri-implant tissues. Hence, the aim of this case-control study was to estimate the 
diagnostic accuracy of the standard clinical parameters to diagnose healthy peri-implant tissues, peri-
implant mucositis, and peri-implantitis. 
 
 
Material and methods 
The present case-control study was conducted in accordance with the Helsinki declaration of human 
studies and received approval from the ethics committee from the University of Extremadura 
(Badajoz, Spain; approval # 18002909) as monitoring center. Moreover, this study was registered and 
approved by www.clinicaltrials.gov (NCT 03031392). The current study was reported according to 





All participants enrolled had to be consecutively evaluated in the routine peri-implant maintenance 
therapy with dental implants in function with fixed prosthesis for a minimum of 12 months after final 
prosthesis delivery from July 2016 up to April 2017. Patients were contacted and informed to 
participate in a cross-sectional assessment to identify the presence of peri-implant diseases or the 
evaluation was carried out during supportive periodontal/peri-implant therapy. Baseline periapical x-
ray at the time of prosthesis delivery was retrospectively assessed to exclude implants with excessive 
early peri-implant bone loss before function that might lead to misdiagnosis (i.e., ≥2mm from 
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excluded from the analysis. Two independent examiners conducted the clinical assessment. In order to 
compensate the possible variability of the data prior to the analysis, the Chi
2
 test was applied to check 
for homogeneity. Additionally, to check the homogeneity of the variables provided by the examiners, 
the Kruskal-Wallis statistical method was applied. 
 
A matched case-control study was conducted on 141 implant patients (62.4% males and 37.6% 
females with a mean age of 57.6±10.2 | range=23-79 years). Of these patients, 47 patients had 
implants with mucositis, 47 patients with peri-implantitis and remaining 47 patients with healthy 
implants. These made an overall of 262 implants where 90 were healthy, 76 with mucositis and 96 
with peri-implantitis. In total, 1572 sites were evaluated. Table 1 presents the demographic data at 
patient-, implant- and site-specific levels. 
 
Eligibility criteria 
The following inclusion criteria were applied: patients within the age range of 18 to 80, non- or light-
smokers (<10 cigarettes/day), no presence of infectious diseases at the time of implant placement or 
during the maintenance program, implants placed in pristine bone, no presence of systemic disease or 
condition or medication known to alter bone metabolism (i.e. bisphosphonates), partial edentulous 
patients without sign of active periodontal disease with or without history of chronic periodontitis. On 
the contrary, individuals were excluded for the following reasons: pregnancy, lactation, history of or 
current heavy smoking (≥10 cig/day), uncontrolled medical conditions such as diabetes mellitus, not 
adequate 3-dimensional implant position, implants placed in sites known to have received grafting 
procedures to augment the edentulous ridges, cement-retained restorations, not properly restored (i.e., 
overcontoured) impeding accurate probing depth recording or lack/minimal of keratinized mucosa.  
 
Case definition of peri-implant mucositis 
As suggested by the AAP academy statement
11
 and the VIII EFP Workshop
10
 peri-implant mucositis 
was defined as an inflammatory condition that courses with swelling (tumor) and bleeding in the lack 
of radiographic peri-implant marginal bone loss beyond initial physiological bone remodeling. As 
such, implants with no bleeding, or only bleeding on probing at one surface assuming a point of 
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considered healthy. On the other side, overt bleeding (≥2 sites), tissue edema with minimal isolated or 




Case definition of peri-implantitis 
Definition peri-implantitis based was based upon clinical inflammation combined with radiographic 
bone loss. Accordingly, the presence of clinical inflammation in combination with radiographic bone 
loss >2mm as earlier proposed in the VIII EFP Workshop
10
 The landmark used to evaluate the peri-
implant bone level was the neck in the case of rough full-bodied implants, or the rough-to-smooth 
interface in case of tissue level implants. As such, signs as presence of suppuration, bleeding on 
probing, mucosal redness, and probing depth were recorded at 6 sites per implant applying 0.15N/cm 




Alternative case definitions of peri-implantitis 
Besides of the case definition proposed in the VIII EFP Workshop,
10
 alternative case definitions as 
proposed elsewhere
29
 were further applied to assess the diagnostic accuracy. As such, peri-implant 
marginal bone loss of ≥0.5mm, ≥1mm, ≥3mm and ≥4mm in the presence of clinical inflammation 
were thresholds to study on the different case definitions for peri-implantitis.   
 
Radiographic assessment 
One calibrated (AM) examiner conducted the radiographic assessment. The peri-implant radiographic 
bone loss (RBL) was determined by taking linear measurements from the most mesial and distal point 
of the implant platform to the crestal bone on each peri-apical radiograph, corrected according to the 
known height and width of each implant using ImageJ (National Institute of Health). Moreover, a 
baseline x-ray (after prosthesis delivery) was obtained from the records to measure the initial 
physiological marginal bone loss to determine the progressed bone loss as consequence of an 
inflammatory condition (i.e. peri-implantitis). 
Clinical assessment 
The following clinical parameters were recorded: probing pocket depth (PPD), plaque index (PI), 
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parameters were recorded at 6 sites per implant. In addition, the implant’s neck design was subdivided 
in tissue-level or bone-level according to implant’s manufacturer description to further investigate the 
impact of these on the peri-implant disease-related parameters. 
 
Statistic analysis 
The statistical package SPSS 15.0 was used to analyze the data. The three diagnosed groups were 
compared in pairs, aiming to identify the factors related to patient, implant and clinical parameters in 
the site able to distinguish between groups. The inferential analysis consisted of estimation by 
generalized estimating equations (GEE) of multilevel logistic regression models. Three levels of 
analyses were taken into consideration: patient, implant and site. The impact or degree of association 
between a predictive factor and the implant diagnose were estimated as odds ratio (OR) and 
confidence interval of 95% using a Chi
2
 of Wald statistical test. The exactitude of the outcomes 
studied was evaluated by means of tables of classification of forecasts against real diagnoses. The 
statistical significance used in the analysis was set to 5% (α=0.05).  
A logistic model was described for the association between the outcome and an independent factor of 
2 levels to reach a power of 80% to detect a significant OR of 2.0 within the sample, assuming a 95% 






Diagnostic accuracy of peri-implant mucositis-related parameters vs. health  
The following parameters demonstrated significance: 
 BOP: A site presenting as BOP+ significantly increased its diagnosis as mucositis (OR=3.56; 
p<0.001). The multiple logistic regression further demonstrated significance (OR=2.13; 
p=0.013). 
 MR: A site presenting as MR+ significantly increased its diagnosis of mucositis (OR=7.66; 
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 PPD: The mean PPD for healthy implants was 2.63±1.21mm and for mucositis was 
3.26±1.57mm. For each 1mm of increased PPD, it significantly increased its diagnosis of 
mucositis by 48% (OR=1.48; p<0.001). The multiple logistic regression further demonstrated 
every 1mm increase of PPD (OR=1.39; p=0.001) was associated with a 39% greater 
likelihood of mucositis. 
 
Accordingly, the following equation summarizes the findings to accurately diagnose peri-implant 




Therefore, 90.3% of the sites could be accurately diagnosed as healthy, showing high specificity, 
while only 43.6% could accurately diagnose mucositis, demonstrating low sensitivity. The positive 
and negative predictive values were 71.2% and 74.4%, respectively. As such, in total, 73.7% implants 
were accurately diagnosed using this diagnostic formula. The area under curve (AUC) of the ROC 
curve (Figure 2) associated to logistic model was 0.77 (95%CI: 0.74-0.89). 
 
Diagnostic accuracy of peri-implantitis-related parameters vs. health  
The following parameters demonstrated significance:  
 BOP: A site presenting BOP+ significantly increased its diagnosis of peri-implantitis 
(OR=2.32; p=0.003). However, with adjustment via the multiple logistic regression model, no 
significance was observed. 
 MR: A site presenting MR+ significantly increased its diagnosis of peri-implantitis 
(OR=7.21; p<0.001). The multiple logistic regression model further demonstrated 
significance (OR=3.28; p=0.003). 
 PPD: The mean PPD for healthy implants was 2.63±1.21mm and for peri-implantitis was 
4.58±1.71mm. For each 1mm of increased PPD, it significantly increased its diagnosis of 
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demonstrated significance for every 1mm increase of PPD (OR=2.03; p<0.001) a 200% 
greater the odds of peri-implantitis. 
 SUP: A site presenting SUP+ significantly increased its diagnosis of peri-implantitis 
(OR=6.81; p<0.001). However, the multiple logistic regressions model did not display 
significance. 
 
Moreover, PI was observed to play a dominant role in the peri-implantitis status, as PI was 
significantly higher at sites diagnosed with peri-implantitis  (OR=2.32; p=0.003). Although not 
reaching statistical significance, the logistic regression model did verify its importance (OR=1.7; 
p=0.096) 
 
Accordingly, the following equation summarizes the findings to accurately diagnose peri-implantitis 
when compared to healthy sites based on the described clinical parameters (Figure 3):  
 
Applying the equation in Figure 3, the sensitivity to diagnose peri-implantitis was 52.5% with a 
specificity of 92.1%. The positive and negative predictive values were 72.7% and 82.8% respectively. 
As such, in total, 82.8% implants were accurately diagnosed using this model system. The area under 




Diagnostic accuracy of peri-implantitis-related parameters vs. mucositis 
 The following parameters demonstrated significance:  
 PPD: For each 1mm of increased PPD, each site significantly increased its diagnosis of peri-
implantitis (OR=1.76; p<0.001). The multiple logistic regression model demonstrated with 
statistical significance that every 1mm increase of PPD (OR=1.75; p<0.001) was associated 
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 SUP: Although statistical significance was not achieved, a site presenting SUP+ showed a 
positive trend associated with peri-implantitis compared to mucositis sites (OR=2.5; 
p=0.088). 
 
Moreover, PI demonstrated to have a dominant role in peri-implantitis, as it was significantly more 
present in sites diagnosed with peri-implantitis  (OR=3.46; p=0.001). Although not reaching statistical 
significance, the logistic regression model could verify its importance (OR=3.40; p=0.002) 
 
Consequently, the following equation summarizes the findings to accurately diagnose peri-implantitis 
when compared to mucositis sites based on the clinical parameters:  
 
Therefore, applying that equation, the sensitivity to diagnose peri-implantitis when compared to 
mucositis was 58.2% with a specificity of 81.3%. The positive and negative predictive values were 
71.9% and 70.2%, respectively. The area under curve (AUC) of the ROC curve (see supplementary 




Association of implant’s neck design and peri-implant disease-related parameters 
Tissue-level compared to bone-level implants were less associated with SUP+ (OR=0.20; p=0.041), 
and PI (OR=0.36; p=0.002), representing a lower risk of 80% and 64% of being present in tissue-level 
Implants, respectively. A linear regression was calculated for PPD and it was shown that tissue-level 
implants have an average reduction of 0.38mm compared to bone-level implants, showing a 
considerable trend towards significance (p=0.082). Conversely, neither BOP nor MR displayed 
significance (p=0.803 and p=0.554, respectively). 
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While neither gender nor age significantly influenced the odds of a health, mucositis or peri-
implantitis diagnosis, the function time was associated on the diagnostic accuracy when health was 
compared to peri-implantitis (OR=2.44; p<0.001) and when mucositis was compared to peri-
implantitis (OR=1.87; p<0.001).  
 
In addition, the following parameters were statistically significantly associated to patient-specific 
factors: 
 PI was associated solely with function time (OR=1.27; p<0.001) 
 BOP+ was associated with gender (females OR=2.27; p<0.001) and age (each increased year 
of age OR=1.03; p=0.010) 
 MR+ was associated with gender (females OR=2.17; p=0.023) and function time (OR=1.22; 
p=0.002) 
 PPD+ was associated with gender and function time. As such, PPD in females was on average 
0.69mm greater than in males (p=0.001) and each year in function was 0.22mm greater 
(p<0.001) 
 SUP+ was associated only with gender (females OR=3.05; p=0.006) 
 
Diagnostic accuracy for alternative peri-implantitis case definitions (Table 2) 
 RBL ≥0.5mm: To define peri-implantitis compared to health, BOP+ (OR=1.87; p=0.040), 
PPD (OR=1.99; p<0.001), MR+ (OR=4.67; p=0.004) and SUP+ (OR=4.68; p=0.045) 
demonstrated significance; and to define peri-implantitis compared to mucositis only PI 
(OR=1.94; p=0.091), and BOP+ (OR=1.04; p=0.025) reached significance. 
 RBL ≥1mm: To define peri-implantitis to health, BOP+ (OR=2.52; p<0.001), PPD (OR=2.04; 
p<0.001), MR+ (OR=45.28; p<0.001) and SUP+ (OR=3.89; p=0.018) demonstrated 
significance; and to define peri-implantitis compared to mucositis only PI (OR=2.62; 
p=0.010) reached significance. 
 RBL ≥3mm: To define peri-implantitis compared to health, PI (OR=2.27; p=0.009), BOP+ 
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(OR=5.45; p=0.010) demonstrated significance; and to define peri-implantitis compared to 
mucositis only PI (OR=2.44; p=0.017), and BOP+ (OR=1.71; p=0.001) reached significance. 
 RBL ≥4mm: To define peri-implantitis compared to health, BOP+ (OR=2.33; p=0.044), PPD 
(OR=3.03; p<0.001), and MR+ (OR=5.51; demonstrated significance; and to define peri-
implantitis compared to mucositis only PPD (OR=1.33; p<0.024) reached significance. 
 
Discussion 
Peri-implant diseases are defined by inflammatory, clinical, and radiographic findings.
13
 While peri-
implantitis was characterized as progressive bone pathology, according to the case definition, the 
clinical parameters have been a matter of discussion due to implication of a variety of biological and 
implant-related factors affecting their respective accuracy.
1, 12, 32, 33
 The present investigation estimated 
the diagnostic accuracy of the clinical parameters for diagnosis of peri-implant diseases using 
advanced analytical algorithms intended for validation and standardization of diagnostic parameters. 
Additionally, the study was carefully designed to constitute a representative study sample regarding 
qualitative and quantitative characteristics to ensure highly reliable outcomes. Our study agreed on the 
fact that the diagnosis of peri-implant conditions could be led by monitoring the clinical parameters, 
being PPD the most reliable prognostic indicator of disease progression followed by MR and BOP, 
particularly on the diagnosis of peri-implant mucositis compared to health.  However, it is noteworthy 
that none of these parameters can be used alone for the diagnosis; rather a combination of them is 
required. While high specificity was presented in all the scenarios, sensitivity remained modest. 
Therefore, these findings are consistent with previous studies
24, 34-37
 suggesting that these clinical 
parameters must be cautiously interpreted for adequate diagnosis. 
 
- Probing pocket depth (PPD) 
The establishment of biological width around implants mandates the consistent PPD monitoring, 
which indicates a shift from a non-pathologic to pathologic status 
24, 36, 38, 39
. Indeed, the present study 
has shown that PPD significantly differs according to the peri-implant condition. Interestingly, it was 
demonstrated that these could vary based on the implant-neck design. An animal study found that 
healthy implants with a supra-crestal polished collar (i.e., tissue level) tends to have a roughly similar 
biological width to natural teeth in contrast with bone level implants 
40
. These findings can be 










 especially in the presence of inflammation.
15
 Other factors significantly influencing 
the PPD included patient gender and implant time in function. For example, PPD increased 0.22 mm 
every year the implant remained in function. This finding could be explained as ‘progressive bone 
loss’ increases over time in function and is supported by the previous study.
1
 Also, greater the peri-
implant bone loss was observed with more apical migration of the long junctional epithelium and 
connective tissue.
17
 Moreover, the increase of PPD, together with BOP+, was associated with the 




- Bleeding on probing (BOP) 
In the field of periodontology, the lack of BOP+ was proven to be a predictor for the periodontal 
tissue stability.
19, 43
 In contrast, Ericsson & Lindhe using beagle dogs reported that a deeper probe 
penetration with BOP+ does not necessarily reflect disease, as it was displayed around healthy 
implants as well.
22
 Interestingly, Lang et al. did not notice BOP+ around healthy implants, while it 
was significantly present in mucositis (67%) and peri-implantitis (91%) sites.
17
 Recent clinical studies 





instance Merli et al. found the odds ratio of a site to be BOP+ by 1.81 for each 1mm increment in 
PPD.
44
 Conversely, Fransson et al. showed that BOP+ occurred in more than 90% of implants with no 
progressive bone loss, indicating that such measurement cannot be used alone for the detection of 
peri-implantitis.
24
 The multiple logistic regression conducted in the present study identified BOP+ to 
be sensitive in the diagnosis of peri-implant mucositis compared to healthy conditions (OR=2.13). 
Nevertheless, the generalized estimating equations indicated that BOP+ is significantly associated 
with peri-implantitis compared to health (OR=2.32).  
 
Moreover, the present study is consistent with previous findings in regard to the manifestation of 
BOP+ in females.
30
 Thus, there is speculation that the transient increase of gingival inflammation 
owing to hormonal variations might mislead the periodontal and peri-implant conditions. 
Additionally, age also reached significance, agreeing then previous findings when probing natural 
teeth.
31
 This fact is reasonable as with age increases the intake of anticoagulant medications. In 
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- Mucosal redness (MR) 
The phenomenon of inflammation presents as a biological response to extrinsic or intrinsic insult. The 
Roman physician Cornelius Celsus (ca. 30 BC–38 AD) described four cardinal signs including rubor, 
calor, tumor and dolor.
46
 Rubor (redness) is increased in the tissues as a result of the vasodilation 
during the onset and process of inflammation. The cause-effect relationship of plaque accumulation 
on soft tissue condition was demonstrated around natural dentition 
47
 and dental implants.
48
 The 
present study found that MR is an accurate diagnostic tool to monitor the presence of pathology. 
Accordingly, when applied the multiple logistic regression, statistical significance was reached for the 
diagnosis of mucositis and peri-implantitis compared to health. Interestingly, a correlation between 
MR+ and female gender was observed. Unsurprisingly, this finding was concomitant with BOP+. 
Again, the hypothesis of the hormonal variations could explain this observation. These findings 
should be interpreted with caution as the patients evaluated presented with an adequate band of 




- Suppuration (SUP) 
Suppuration is defined as a pus formation followed by discharge within a natural aperture or fistula. 
Pus qualitatively represent the turbid viscous inflammatory exudate consisting of dead leukocytes, 
living or dead microorganisms, necrotic tissues, and protein-rich fluid called liquor puris rich in pro-
inflammatory mediators and bacterial toxins. These components represent byproducts of the host 
reaction directed towards to persistent pathological irritants (e.g., infection or foreign body). 
Therefore, SUP is accepted as a highly specific clinical parameter of peri-implant inflammation since 
it reflects ongoing inflammatory processes in the tissues.
3
 For that reason, SUP was initially 
associated with the progressive forms of periodontal disease and recently has been proposed as an 
indicator for progressive bone loss on implants.
24, 34
 In this regard, low predictability rate of SUP+ in 
peri-implant mucositis together with inversely high predictability in peri-implantitis confirms the SUP 
as an accurate clinical endpoint to disclose peri-implant bone loss 
34
. In agreement with those 
findings, the estimated predictability of SUP+ was compatible at both implant (OR=1.47) and site 
level (OR=6.81), thus supporting the accuracy of this parameter for dental implant diseases 
monitoring. Nevertheless, it is worth mentioning, that SUP did not reach significance for the logistic 
regression model, as it might have been masked by other more discriminative parameters (i.e. BOP or 
MR). Moreover, in line with findings related to other parameters investigated, SUP was more 
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higher proportions of PI together with other signs of inflammation such as MR+ and BOP+. It is, 
therefore the authors’ opinion that future research studies should aim to identify peri-implantitis 
patient clusters that discern SUP and related underlying factors. 
 
Recommendations for future research 
Peri-implant diseases represents a growing problem in the current field of dentistry due to increasing 
prevalence and lack of standard treatment protocols.
9
 Additionally, peri-implant diseases have a 
progressive and asymptomatic course. In that context, the reliable diagnostic protocol for the adequate 
monitoring of peri-implant tissues remains of essential importance. The results of the present study 
clearly demonstrate that the assessment of multiple clinical parameters provide more accurate 
diagnostic information simultaneously, suggesting the limitation of using isolated clinical parameters 
for the diagnosis of peri-implant diseases. When considering the results as a whole, investigation of 
the biological features of peri-implant tissues and better understanding of the underlying 
pathogenetical mechanisms will certainly contribute to improvement of the peri-implant diagnostics. 
This will continue to be a charge for future research. Furthermore, it seems that the personalized 
medicine approach proposed for multifactorial diseases and combines multiple clinical and biological 
markers might be a promising tool in monitoring peri-implant tissues. 
 
Conclusion 
The diagnosis of peri-implant diseases cannot rely on a single clinical parameter but rather requires a 
combination. This study showed that the clinical parameters, in particular probing pocket depth, might 
accurately discern between diagnoses among peri-implant conditions. Nevertheless, the specificity of 
the clinical parameters surpasses the sensitivity in the detection of peri-implant diseases. Therefore, 
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Table 1. Table of demographics at patient- implant- and site-levels 
 
  Category N % Mean ± SD Total 
Patient Level 
(N=141) 
Group Healthy 47 33.3   
 Mucositis 47 33.3   
 Peri-implantitis 47 33.3   
Age (years)    57.6 ± 10.2  
Gender Men 88 62.4   
Women 53 37.6   
N. Implants    1.9 ± 1.3 262 
N. Healthy Implants    0.9 ± 1.2 127 
N. Mucositis Implants    0.5 ± 1.9 74 
Num. Peri-implantitis Implants    0.4 ± 0.7 61 
Implant Level (N=262) Group Healthy 127 48.5   
 Mucositis 74 28.2   
 PI 61 23.3   
Time in function (years)    3.17 ± 2.04  
Position 
 
MD ant. 26 9.9   
MD post. 97 37.0   
MX ant. 39 14.9   
MX post. 100 38.2   
System NB 84 32.1   
STR 67 25.6   
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BH 27 10.3   
MIS 16 6.1   
Other 16 6.1   
Neck Design BL 205 78.2   
TL 57 21.8   
Rx MBL (mm)    1.06 ± 1.42  
N. Sites with plaque    2.14 ± 2.46  
N. Sites with BOP    2.14 ± 2.28  
PPD Average on Implants (mm)    3.26 ± 1.40  
N. Sites with MR    1.40 ± 2.16  
N. Sites with SUP    0.61 ± 1.71  
Site Level (N=1572) Plaque Yes 560 64.4   
BOP Yes 1011 64.3   
PPD (mm)    3.26 ± 1.57  
MR Yes 347 23.3   
Suppuration Yes 159 10.1   
MD= mandibular; MX=maxillary; ant=anterior; post=posterior; BL= bone level; TL= tissue level; Rx MBL=radiographic marginal bone loss; BH=Biohorizon (Birmingham, AL); 
MG=MozoGrau (Valladolid, Spain); NB=Nobel Biocare (Gothenburg, Sweden); STR=Straumann (Basel, Switzerland); MIS (Savion, Israel) 
 
 
Table 2. Diagnostic accuracy (%) of the decisive parameters according to the generalized estimating 
equations (GEE) of multilevel logistic regression on the alternative definitions of peri-implantitis 
based upon the different marginal bone loss (MBL) thresholds with signs of inflammation. 
 
 
  Decisive parameters 
(GEE) 
Diagnostic accuracy (%) 
  Site Level S SP Total  
MBL>=0.5 mm Healthy vs. Mucositis PPD 46.1 84.1 71.0 
Healthy vs. Peri-implantitis PPD, MR 92.1 23.6 71.1 
Mucositis vs. Peri-implantitis BOP, PI 100 0 81.2 
MBL>=1 mm Healthy vs. Mucositis PPD, MR, BOP 41.9 87.7 73.0 
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Mucositis vs. Peri-implantitis PI 100 0 72.2 
MBL>=2 mm Healthy vs. Mucositis PPD, MR, BOP 43.6 90.3 73.7 
Healthy vs. Peri-implantitis PPD, MR, PI 52.3 92.1 80.7 
Mucositis vs. Peri-implantitis PPD, PI 58.2 81.3 70.9 
MBL>=3 mm Healthy vs. Mucositis MR, BOP 41.4 91.5 72.2 
Healthy vs. Peri-implantitis PPD, PI 43.8 96.4 87.3 
Mucositis vs. Peri-implantitis PPD, PI 17.3 96.3 78.1 
MBL>=4 mm Healthy vs. Mucositis PPD, MR, BOP 58.5 83.5 72.3 
Healthy vs. Peri-implantitis PPD 14.1 98.3 90.6 
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Figure 1. Graph of the predicted probability of peri-implant mucositis compared to healthy condition 
by different levels of significant predictors from generalized estimating equation (GEE) of multilevel 




Figure 2. Receiving operating characteristics (ROC) curve graph on the sensitivity and specificity to 
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Figure 3. Graph of the predicted probability of peri-implantitis compared to healthy condition by 
different levels of significant predictors from generalized estimating equation (GEE) of multilevel 
logistic regression model.  
 
Figure 4. Receiving operating characteristics (ROC) on the sensitivity and specificity to detect peri-
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